FOSTER CITY, Calif., Oct. 28, 2025 /PRNewswire/ -- Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced the winners of the Illumina–Signios Bio Proteomics Grant Program. The program was established to advance proteogenomic research through access to the Illumina Protein Prep 9.5K™, the industry's largest NGS-based proteomics panel.